Michael D. Collini - Concepedia

Author

Michael D. Collini

Karo Pharma (Sweden)

Also Known As

Michael Collini, Michael D Collini, Michael D. Collini

Publications

738

Citations

H-Index

Concepts

All Affiliations

Karo Pharma (Sweden)Women's Health Research Institute

About

Michael D. Collini is an author at Karo Pharma (Sweden) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	598
2	Biochemistry	5	5	526
3	Natural Sciences	4	4	461
4	Chemistry	4	4	491
5	Chemical Biology	2	2	396

Michael D. Collini

Publications

737

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands Michael S. Malamas, Eric S. Manas, Robert McDevitt, Journal of Medicinal Chemistry Combinatorial ChemistryOrganic ChemistryPharmacotherapyChemistrySelective Analogues	2004	259
Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens Chris P. Miller, Michael D. Collini, Bach D. Tran, Journal of Medicinal Chemistry Altmetric Attention ScoreOrganic ChemistryChemistryChemical BiologyPharmaceutical Chemistry	2001	137
The Solid Phase Synthesis of Tri-Substituted Indoles Michael D. Collini, John W. Ellingboe Tetrahedron Letters Organic ChemistrySolid Phase SynthesisSynthesis MethodChemistrySynthetic Chemistry	1997	85
Constrained phytoestrogens and analogues as ERβ selective ligands Chris P. Miller, Michael D. Collini, Heather A. Harris Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineHormonal ReceptorPhytochemicalPhytochemistry	2003	65
Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRβ Baihua Hu, Raymound Unwalla, Michael D. Collini, Bioorganic & Medicinal Chemistry Molecular PharmacologyDrug TargetFunctional SelectivityMedicineImmunology	2009	51
Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis Baihua Hu, Michael D. Collini, Rayomand J. Unwalla, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceQuinolines 15Biochemistry	2006	50
7-Substituted 2-phenyl-benzofurans as ERβ selective ligands Michael D. Collini, David H. Kaufman, Eric S. Manas, Bioorganic & Medicinal Chemistry Letters Organic ChemistryErβ Selective LigandsPharmacologyCombinatorial Chemistry	2004	44
Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRβ and low blood–brain penetration Baihua Hu, Ron Bernotas, Rayomand J. Unwalla, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyFunctional SelectivityMedicinePharmacological AgentPharmacotherapy	2009	21
Metabolites of the Angiotensin II Antagonist Tasosartan: The Importance of a Second Acidic Group John W. Ellingboe, Michael D. Collini, Dominick Quagliato, Journal of Medicinal Chemistry Medicinal ChemistryEnol MetaboliteBiochemistryMedicineNatural Sciences	1998	15
A highly efficient, one-pot synthesis of benzo[b]fluoren-10-ones Michael D. Collini, Chris P. Miller Tetrahedron Letters One-pot SynthesisFluorous SynthesisOrganic ChemistrySynthesis MethodChemistry	2001	10

Page 1